Company Filing History:
Years Active: 1997-2002
Title: John Gerald Ward: Innovator in Pharmaceutical Chemistry
Introduction
John Gerald Ward is a notable inventor based in Barnet, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Ward holds 2 patents, with his latest innovations focusing on hydroxamic acid derivatives and tryptamine analogues. His patent titled "Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF release" describes compounds that are useful in treating disorders mediated by s-CD23. Another significant patent is "Tryptamine analogues as 5-HT1-like agonists," which explores the potential of these compounds in therapeutic settings.
Career Highlights
John Gerald Ward is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research in pharmaceutical compounds. His work has contributed to the understanding and development of new treatments for various medical conditions.
Collaborations
Throughout his career, Ward has collaborated with notable colleagues, including Roderick Alan Porter and Andrew Faller. These collaborations have fostered innovation and have been pivotal in the success of his research endeavors.
Conclusion
John Gerald Ward's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to impact the development of new therapeutic agents.